Crixivan

Medicinal product

(Invented) name

Crixivan

Active substance (s)

Indinaviras

Strength

400 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AE02, Indinavir

Marketing authorisation holder

Merck Sharp & Dohme B.V., Nyderlandai

Date of authorisation

1996-10-04

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

capsule, hard	1 vnt.
Indinaviras	400 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
25749	28346	1028346	buteliukas	N90		Receptinis	EU/1/96/024/004	Netiekiama	-	-	No	-	-
5008	10322	1010322	buteliukas	N180		Receptinis	EU/1/96/024/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-03-26	Išregistruotas
1996-10-04	Registruotas